본문 바로가기
KERD
논문KCI 등재

Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway

박소영|김재룡|최형철|Sung Jin Young|Kim Seul Gi
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2024.12|Experimental and Molecular Medicine|제56권 |pp. 1967-1979|DOI 10.1038/s12276-024-01297-w

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Telomere dysfunction is a well-known molecular trigger of senescence and has been associated with various age-related diseases, including atherosclerosis. However, the mechanisms involved have not yet been elucidated, and the extent to which telomeres contribute to atherosclerosis is unknown. Therefore, we investigated the mechanism of metformin-induced telomere stabilization and the ability of metformin to inhibit vascular smooth muscle cell (VSMC) senescence caused by advanced atherosclerosis. The present study revealed that metformin inhibited the phenotypes of atherosclerosis and senescence in VSMCs. Metformin increased the phosphorylation of AMPK-dependent PGC-1α and thus increased telomerase activity and the protein level of TERT in OA-treated VSMCs. Mechanistically, the phosphorylation of AMPK and PGC-1α by metformin not only enhanced telomere function but also increased the protein level of TERT, whereas TERT knockdown accelerated the development of atherosclerosis and senescent phenotypes in OA-treated VSMCs regardless of metformin treatment. Furthermore, the in vivo results showed that metformin attenuated the formation of atherosclerotic plaque markers in the aortas of HFD-fed ApoE KO mice. Although metformin did not reduce plaque size, it inhibited the phosphorylation of the AMPK/PGC-1α/TERT signaling cascade, which is associated with the maintenance and progression of plaque formation, in HFD-fed ApoE KO mice. Accordingly, metformin inhibited atherosclerosis-associated phenotypes in vitro and in vivo. These observations show that the enhancement of telomere function by metformin is involved in specific signaling pathways during the progression of atherosclerosis. These findings suggest that telomere stabilization by metformin via the AMPK/p-PGC-1α pathway might provide a strategy for developing therapeutics against vascular diseases such as atherosclerosis.

Abstract

Telomere dysfunction is a well-known molecular trigger of senescence and has been associated with various age-related diseases, including atherosclerosis. However, the mechanisms involved have not yet been elucidated, and the extent to which telomeres contribute to atherosclerosis is unknown. Therefore, we investigated the mechanism of metformin-induced telomere stabilization and the ability of metformin to inhibit vascular smooth muscle cell (VSMC) senescence caused by advanced atherosclerosis. The present study revealed that metformin inhibited the phenotypes of atherosclerosis and senescence in VSMCs. Metformin increased the phosphorylation of AMPK-dependent PGC-1α and thus increased telomerase activity and the protein level of TERT in OA-treated VSMCs. Mechanistically, the phosphorylation of AMPK and PGC-1α by metformin not only enhanced telomere function but also increased the protein level of TERT, whereas TERT knockdown accelerated the development of atherosclerosis and senescent phenotypes in OA-treated VSMCs regardless of metformin treatment. Furthermore, the in vivo results showed that metformin attenuated the formation of atherosclerotic plaque markers in the aortas of HFD-fed ApoE KO mice. Although metformin did not reduce plaque size, it inhibited the phosphorylation of the AMPK/PGC-1α/TERT signaling cascade, which is associated with the maintenance and progression of plaque formation, in HFD-fed ApoE KO mice. Accordingly, metformin inhibited atherosclerosis-associated phenotypes in vitro and in vivo. These observations show that the enhancement of telomere function by metformin is involved in specific signaling pathways during the progression of atherosclerosis. These findings suggest that telomere stabilization by metformin via the AMPK/p-PGC-1α pathway might provide a strategy for developing therapeutics against vascular diseases such as atherosclerosis.

참고문헌 (71)

  1. Grootaert, M. O. J., "Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis", Cardiovasc. Res, 114, pp.622~634 (2018)
  2. Lacolley, P., "Vascular smooth muscle cells and arterial stiffening : relevance in development, aging, and disease", Physiol. Rev, 97, pp.1555~1617 (2017)
  3. Libby, P., "Inflammation in atherosclerosis", Nature, 420, pp.868~874 (2002)
  4. Mazurek, R., "Vascular cells in blood vessel wall development and disease", Adv. Pharm, 78, pp.323~350 (2017)
  5. Shammas, M. A., "Telomeres, lifestyle, cancer, and aging", Curr. Opin. Clin. Nutr. Metab. Care, 14, pp.28~34 (2011)
  6. Herrmann, W., "The Importance of telomere shortening for atherosclerosis and mortality", J. Cardiovasc Dev. Dis, 7, pp.29~ (2020)
  7. Chen, M. S., "Senescence mechanisms and targets in the heart", Cardiovasc. Res, 118, pp.1173~1187 (2022)
  8. Lin, J., "Stress and telomere shortening : Insights from cellular mechan isms", Ageing Res. Rev, 73, pp.101507~ (2022)
  9. Rietzschel, E. R., "Telomeres and atherosclerosis: the attrition of an attractive hypothesis", J. Am. Coll. Cardiol, 67, pp.2477~2479 (2016)
  10. Sanchez-Rangel, E., "Metformin : clinical use in type 2 diabetes", Diabetologia, 60, pp.1586~1593 (2017)
  11. Hu, D., "Metformin : a potential candidate for targeting aging mechanisms", Aging Dis, 12, pp.480~493 (2021)
  12. Glossmann, H. H., "Metformin and aging: a review", Gerontology, 65, pp.581~590 (2019)
  13. Wu, S., "AMPK, mitochondrial function, and cardiovascular disease", Int. J. Mol. Sci, 21, pp.4987~ (2020)
  14. Liu, D., "AMPK", PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis, 2018, pp.129, 59~72
  15. Soltys, C. L. M., "Activation of cardiac AMP-activated protein kinase by LKB1 expression or chemical hypoxia is blunted by increased Akt activity", Am. J. Physiol. Heart Circ. Physiol, 290, pp.H2472~H2479 (2006)
  16. Wang, Q., "AMPK-mediated regulation of lipid metabolism by phosphoryla tion", Biol. Pharm. Bull, 41, pp.985~993 (2018)
  17. Sung, J. Y., "SRT1720-induced activation of SIRT1 alleviates vascular smooth muscle cell senescence through PKA-dependent phosphorylation of AMPKα at Ser485", FEBS Open Bio, 10, pp.1316~1325 (2020)
  18. Cheng, C. F., "PGC-1α as a pivotal factor in lipid and metabolic regulation", Int. J. Mol. Sci, 19, pp.3447~ (2018)
  19. Sung, J. Y., "Metformin mitigates stress-induced premature senescence by upregulating AMPKα at Ser485 phosphorylation induced SIRT3 expression and inactivating mitochondrial oxidants", Mech. Ageing Dev, 206, pp.111708~ (2022)
  20. Itahana, K., "Methods to detect biomarkers of cellular senescence : the senescence-associated beta-galactosidase assay", Methods Mol. Biol, 371, pp.21~31 (2007)
  21. Woo, C. H., "Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells", Circ. Res, 102, pp.538~545 (2008)
  22. Weinmann, A. S., "Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation", Methods, 26, pp.37~47 (2002)
  23. Ourliac-Garnier, I., "Telomere strand-specific length analysis by fluorescent In situ hybridization(Q-CO-FISH)", Methods Mol. Biol, 1587, pp.41~54 (2017)
  24. Cawthon, R. M., "Telomere measurement by quantitative PCR", Nucleic Acids Res, 30, pp.e47~ (2002)
  25. Wang, Y., "Telomeres are elongated in rats exposed to moderate altitude", J. Physiol. Anthropol, 33, pp.19~ (2014)
  26. Beattie, J. H., "Rapid quantification of aortic lesions in apoE(-", -)mice, 2009, pp.46, 347~352
  27. Zha, Y., "Senescence in vascular smooth muscle cells and atherosclerosis", Front. Cardiovasc. Med, 9, pp.910580~ (2022)
  28. Zhou, D., "USP22 down-regulation facilitates human retinoblastoma cell aging and apoptosis via inhibiting TERT", P53 pathway, 2017, pp.21, 2785~2792
  29. Peng, L., "The dual effects of Congea chinensis Moldenke on inhibiting tumor cell proliferation and delaying aging by activating TERT transcriptional activity", J. Ethnopharmacol, 319, pp.117103~ (2024)
  30. Marzullo, M., "Whole-mount senescence-associated beta-galactosidase(SA-β-GAL)activity detection protocol for adult zebrafish", Bio Protoc, 12, pp.e4457~ (2022)
  31. Chen, R., "Phenotypic switching of vascular smooth muscle cells in atherosclerosis", J. Am. Heart Assoc, 12, pp.e031121~ (2023)
  32. Yu, Y., "Berberine improves cognitive deficiency and muscular dysfunction via activation of the AMPK", SIRT1, J. Nutr. Health Aging, pp.2018, 22[DOI]
  33. Zhou, S., "The anti-aging hormone klotho promotes retinal pigment epi thelium cell viability and metabolism by activating the AMPK", PGC-1α pathway, 2023, pp.12, 385~
  34. Lu, W., "Telomeres-structure, function, and regulation", Exp. Cell Res, 319, pp.133~141 (2013)
  35. Dasgupta, B., "Compound c", dorsomorphin : Its use and misuse as an AMPK inhibitor, 2018, pp.1732, 195~202
  36. Fontana, F., "PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma", Biochim Biophys. Acta Mol. Basis Dis, 1870, pp.166897~ (2024)
  37. Herrmann, M., "Telomere biology and age related diseases", Clin. Chem. Lab Med, 56, pp.1210~1222 (2018)
  38. Garcia-Martin, I., "Metformin and insulin treatment prevent placental telo mere attrition in boys exposed to maternal diabetes", PLoS ONE, 13, pp.e0208533~ (2018)
  39. Kato, T. A., "Telomere aberration detection by PNA FISH probe", Methods Mol. Biol, 2519, pp.105~110 (2023)
  40. Zhang, Y., "Regulation of telomere length and athero sclerosis by protection of telomeres 1 protein", J. Nanosci. Nanotechnol, 19, pp.7953~7959 (2019)
  41. Mussazhanova, Z., "Association between p53-binding protein 1 expression and genomic instability in oncocytic follicular adenoma of the thyroid", Endocr. J, 63, pp.457~467 (2016)
  42. Kong, P., "Inflammation and atherosclerosis : signaling pathways and ther apeutic intervention", Signal Transduct. Target Ther, 7, pp.131~ (2022)
  43. Sapan, H. B., "Pattern of cytokine(IL-6 and IL-10)level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome(MODS)in polytrauma", Int. J. Burns Trauma, 6, pp.37~43 (2016)
  44. Hof, A., "Vascular ultrasound for in vivo assessment of arterial pathologies in a murine model of atherosclerosis and aortic aneurysm", Int. J. Mol. Sci, 24, pp.15261~ (2023)
  45. Allahverdian, S., "Smooth muscle cell fate and plasticity in atherosclerosis", Cardiovasc. Res, 114, pp.540~550 (2018)
  46. Libby, P., "Atherosclerosis", Nat. Rev. Dis. Prim, 5, pp.56~ (2019)
  47. Hamczyk, M. R., "Vascular smooth muscle-specific progerin expression accelerates atherosclerosis and death in a mouse model of hutchinson-gilford progeria syndrome", Circulation, 138, pp.266~282 (2018)
  48. Gardner, S. E., "Senescent vascular smooth muscle cells drive inflammation through an interleukin-1α-dependent senescence-associated secretory phenotype", Arterioscler Thromb. Vasc. Biol, 35, pp.1963~1974 (2015)
  49. Garcia, D., "AMPK : mechanisms of cellular energy sensing and restoration of metabolic balance", Mol. Cell, 66, pp.789~800 (2017)
  50. Aslam, M., "Emerging role of cAMP", AMPK signaling, 2022, pp.11, 308~
  51. Hurley, R. L., "Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP", J. Biol. Chem, 281, pp.36662~36672 (2006)
  52. Xiong, S., "PGC-1αmodulates telomere function and DNA damage in protecting against aging related chronic diseases", Cell Rep, 12, pp.1391~1399 (2015)
  53. Xiong, S., "Peroxisome proliferator-activated receptor γ coactivator-1α is a central negative regulator of vascular senescence", Arterioscler Thromb. Vasc. Biol, 33, pp.988~998 (2013)
  54. Armanios, M., "The role of telomeres in human disease", Annu Rev. Genomics Hum. Genet, 23, pp.363~381 (2022)
  55. Smith, E. M., "Structural biology of telomeres and telomerase", Cell Mol. Life Sci, 77, pp.61~79 (2020)
  56. Zheng, Q., "Mitochondria, telomeres and telomerase sub units", Front. Cell Dev. Biol, 7, pp.274~ (2019)
  57. Raha, S., "Mitochondria, oxygen free radicals, disease and ageing", Trends Biochem. Sci, 25, pp.502~508 (2000)
  58. Scarpulla, R. C., "Metabolic control of mitochondrial biogenesis through the PGC-1family regulatory network", Biochim. Biophys. Acta, 1813, pp.1269~1278 (2011)
  59. Cantó, C., "AMPK regulates energy expenditure by modulating NAD+metabolism and SIRT1 activity", Nature, 458, pp.1056~1060 (2009)
  60. Korolchuk, V. I., "Mitochondria in cell senes cence: is mitophagy the weakest link?", EBioMedicine, 21, pp.7~13 (2017)
  61. Foretz, M., "Understanding the glucoregulatory mechan isms of metformin in type 2 diabetes mellitus", Nat. Rev. Endocrinol, 15, pp.569~589 (2019)
  62. Pulipaka, S., "Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation", Geroscience, 46, pp.2391~2408 (2024)
  63. Kulkarni, A. S., "Benefits of metformin in attenuating the hallmarks of aging", Cell Metab, 32, pp.15~30 (2020)
  64. Zhu, H., "Molecular mechanisms of action of met formin: latest advances and therapeutic implications", Clin. Exp. Med, 23, pp.2941~2951 (2023)
  65. Foretz, M., "Metformin : update on mechanisms of action and repurposing potential", Nat. Rev. Endocrinol, 19, pp.460~476 (2023)
  66. Nyane, N. A., "Metformin-like antidiabetic, cardio-protective and non-glycemic effects of nar ingenin: molecular and pharmacological insights", Eur. J. Pharm, 803, pp.103~111 (2017)
  67. Tyrrell, D. J., "Ageing and atherosclerosis : vascular intrinsic and extrinsic factors and potential role of IL-6", Nat. Rev. Cardiol, 18, pp.58~68 (2021)
  68. Shami, A., "Collagen and related extracellular matrix proteins in atherosclerotic plaque development", Curr. Opin. Lipid, 25, pp.394~399 (2014)
  69. Wang, J. C., "Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence", Circ. Res, 111, pp.245~259 (2012)
  70. Vecoli, C., "The molecular biomarkers of vascular aging and atherosclerosis : telomere length and mitochondrial DNA(4977)com mon deletion", Mutat. Res. Rev. Mutat. Res, 784, pp.108309~ (2020)
  71. Deng, Y., "Telomere length and the risk of cardiovascular diseases : a men delian randomization study", Front. Cardiovasc. Med, 9, pp.1012615~ (2022)

관련 논문AI추천

Dual modulation of atherosclerosis by exercise and metformin: convergent pathways, divergent outcomes, and therapeutic potentialLi Hongpeng, Sun Manqi, Xu Shousheng, Zhang Ziyi대한고혈압학회 · Clinical Hypertension2025 · 제31권 Metformin Reduces the Progression of Atherogenesis by Regulating Sestrin2-mTOR Pathway in Obese and Diabetic RatsAnusha Rajagopal, Gautam Kumar Pandey, Isaivani Jayachandran, Kuppan Gokulakrishnan, Muthuswamy Balasubramanyam, Nagaraj Manickam, Saravanakumar Sundararajan, Saravanakumar Venkatesan, Viswanathan Mohan한국지질동맥경화학회 · 지질·동맥경화학회지2023 · 제12권 제3호Cellular Senescence in Arterial DiseasesIppei Shimizu, Tohru Minamino한국지질동맥경화학회 · 지질·동맥경화학회지2020 · 제9권 제1호Anti-malarial Drugs Reduce Vascular Smooth Muscle Cell Proliferation via Activation of AMPK and Inhibition of Smad3 Signaling김수진, 우창훈, 이희정, 조두형, 한정화한국지질동맥경화학회 · 지질·동맥경화학회지2019 · 제8권 제2호Poly(ADP-ribose) protects vascular smooth muscle cells from oxidative DNA damageChao Zhang, Chunjing Bian, Shijun Cui, Tao Luo, Xiaochun Yu, Yibin Chen, Yongquan Gu, Zhonggao Wang생화학분자생물학회 · BMB Reports2015 · 제48권 제6호NAD+ and Vascular Dysfunction: From Mechanisms to Therapeutic OpportunitiesAbdellatif Mahmoud, Guido Kroemer, Heiko Bugger, Simon Sedej한국지질동맥경화학회 · 지질·동맥경화학회지2022 · 제11권 제2호

이 간행물의 다른 논문 (218건)

Big data and deep learning for RNA biologyJeon Hyeonseong, Baek Daehyun, Hwang Hyeonseo, Yeo Nagyeongpp. 1-29RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinomaXu Yanan, Ke Shanjia, Lu Shounan, Bai Miaoyu, Yu Hongjun, Yin Bing, Wang Chaoqun, Feng Zhigang, Li Zihao, Huang Jingjing, Li Xinglong, Qian Baolin, Hua Yongliang, Fu Yao, Sun Bei, Wu Yaohua, Ma Yongpp. 1-14Molecular mechanisms of circular RNA translationKim Yoon Ki, Hwang Hyun Jungpp. 1-9The m6A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolismKim Ho, Yun Hye Jin, 이종호, Lee Su Bin, Kim Seok-Ho, Park Yun-Yong, Park Su Hwan, Ju Jin-Sung, Woo Hyunmin, Győrffy Balázs, Kim Eun-jeong, Han Hee Dong, Eyun Seong-ilpp. 1-15Neuron type-specific optogenetic stimulation for differential stroke recovery in chronic capsular infarctKim Ra Gyung, Cho Jongwook, Park Ji-Young, Kim Young Ro, Lee Min-Cheol, Kim Hyoung-Ihlpp. 1-11
원문 보기